Henderson Jeffrey William
SEC CIK 1324015 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Dir | 36.6K | — | $2.34M | 11 | 2022-05-05 | 2026-05-05 |
| QCOM | Qualcomm | Dir | 14.6K | — | $620.6K | 11 | 2022-03-12 | 2026-03-17 |
| BDX | Becton Dickinson | Dir | 9,143 | $350.4K | — | 6 | 2022-01-25 | 2026-01-27 |
| KYNB | KYNTRA BIO, INC. | Dir | 28.9K | — | $133.4K | 6 | 2022-06-16 | 2023-09-01 |
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 11 | Henderson Jeffrey William | Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-07 19:02 | 2026-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +3,796 | 36.6K | +12% | $0 |
| 2026-03-18 | 2026-03-17 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +2,563 | 14.6K | +21% | $0 | |
| D | 2026-03-09 | 2026-03-08 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | D - Sale to Iss | $135.69 | -759 | 12.0K | -6% | -$103.0K |
| D | 2026-03-09 | 2026-03-08 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | M - OptEx | $0.00 | +2,355 | 12.8K | +23% | $0 |
| 2026-01-29 | 2026-01-27 | BDX | Becton Dickinson | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +1,098 | 9,143 | +14% | $0 | |
| D | 2025-05-02 | 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +4,165 | 32.8K | +15% | $0 |
| M | 2025-04-28 | 2025-04-28 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | S - Sale | $60.37 | -4,497 | 28.6K | -14% | -$271.5K |
| 2025-04-01 | 2025-04-01 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | S - Sale | $64.05 | -503 | 33.1K | -1% | -$32.2K | |
| 2025-03-20 | 2025-03-18 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +2,097 | 10.4K | +25% | $0 | |
| D | 2025-03-10 | 2025-03-09 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | M - OptEx | $0.00 | +1,901 | 8,309 | +30% | $0 |
| M | 2025-03-03 | 2025-03-03 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | S - Sale | $58.69 | -5,000 | 36.8K | -12% | -$293.5K |
| 2025-02-10 | 2025-02-10 | BDX | Becton Dickinson | Henderson Jeffrey William | Dir | P - Purchase | $233.62 | +1,500 | 8,015 | +23% | +$350.4K | |
| M | 2025-02-04 | 2025-02-03 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | S - Sale | $56.31 | -5,000 | 38.6K | -11% | -$281.5K |
| 2025-01-30 | 2025-01-28 | BDX | Becton Dickinson | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +930 | 6,515 | +17% | $0 | |
| 2025-01-07 | 2025-01-06 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | S - Sale | $50.01 | -10.0K | 43.6K | -19% | -$500.1K | |
| D | 2024-04-29 | 2024-04-25 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +6,501 | 53.6K | +14% | $0 |
| D | 2024-03-11 | 2024-03-10 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | M - OptEx | $0.00 | +2,056 | 6,408 | +47% | $0 |
| 2024-01-25 | 2024-01-23 | BDX | Becton Dickinson | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +900 | 5,568 | +19% | $0 | |
| 2023-09-06 | 2023-09-01 | KYNB | KYNTRA BIO, INC. | Henderson Jeffrey William | Dir | S - Sale | $1.03 | -2,000 | 28.9K | -6% | -$2,060 | |
| 2023-08-08 | 2023-08-04 | KYNB | KYNTRA BIO, INC. | Henderson Jeffrey William | Dir | S - Sale | $1.91 | -2,000 | 30.9K | -6% | -$3,820 | |
| 2023-07-13 | 2023-07-11 | KYNB | KYNTRA BIO, INC. | Henderson Jeffrey William | Dir | S - Sale | $2.69 | -2,000 | 32.9K | -6% | -$5,380 | |
| DM | 2023-06-09 | 2023-06-08 | KYNB | KYNTRA BIO, INC. | Henderson Jeffrey William | Dir | S - Sale | $17.46 | -7,000 | 34.9K | -17% | -$122.2K |
| D | 2023-06-09 | 2023-06-07 | KYNB | KYNTRA BIO, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +8,289 | 41.9K | +25% | $0 |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +8,065 | 47.1K | +21% | $0 |
| D | 2023-03-13 | 2023-03-10 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | D - Sale to Iss | $115.19 | -1,069 | 4,352 | -20% | -$123.1K |
| D | 2023-03-13 | 2023-03-10 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | M - OptEx | $0.00 | +3,316 | 5,421 | +158% | $0 |
| M | 2023-03-01 | 2023-02-28+ | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | S - Sale | $48.11 | -20.0K | 39.0K | -34% | -$962.2K |
| M | 2023-02-24 | 2023-02-22+ | QCOM | Qualcomm | Henderson Jeffrey William | Dir | S - Sale | $124.12 | -5,000 | 2,105 | -70% | -$620.6K |
| 2023-01-26 | 2023-01-24 | BDX | Becton Dickinson | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +848 | 4,653 | +22% | $0 | |
| D | 2022-06-21 | 2022-06-16 | KYNB | KYNTRA BIO, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +15.8K | 33.6K | +89% | $0 |
| 2022-05-06 | 2022-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +6,206 | 59.0K | +12% | $0 | |
| D | 2022-03-15 | 2022-03-12 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | D - Sale to Iss | $152.34 | -1,469 | 7,105 | -17% | -$223.8K |
| D | 2022-03-15 | 2022-03-12 | QCOM | Qualcomm | Henderson Jeffrey William | Dir | M - OptEx | $0.00 | +4,559 | 8,574 | +114% | $0 |
| 2022-01-26 | 2022-01-25 | BDX | Becton Dickinson | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +820 | 3,777 | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations